New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 13, 2014
07:05 EDTBLRXBioLineRx files submissions to begin Phase 1 trial for BL-8040
ioLineRx announced that it has filed the necessary regulatory submissions to commence a Phase 1 trial for BL-8040, a novel treatment for the mobilization of stem cells from the bone marrow to the peripheral blood circulation. The regulatory submissions were filed with the Hadassah Medical Center Institutional Review Board, or IRB, and the study is expected to commence during the Q2.
News For BLRX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for BLRX

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use